Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Epigenetics

• Publication date

  2016-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/15592294.2016.1145327PMID 26891149PMCID PMC4846096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How I treat juvenile myelomonocytic leukemia.

  2015cited by this paper
• Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis

  2015cited by this paper
• Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis.

  2014influential reference
• RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia

  2014influential reference
• Identification of DNA methylation changes at cis-regulatory elements during early steps of HSC differentiation using tagmentation-based whole genome bisulfite sequencing

  2014influential reference
• Charting a dynamic DNA methylation landscape of the human genome

  2013cited by this paper
• Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia.

  2012cited by this paper
• The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells

  2012cited by this paper
• Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.

  2011influential reference
• Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.

  2010cited by this paper
• Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia

  2010cited by this paper
• Linking cell signaling and the epigenetic machinery

  2010cited by this paper
• Down‐regulation of tumor suppressor a kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms

  2010influential reference
• SSeCKS/Gravin/AKAP12 Inhibits Cancer Cell Invasiveness and Chemotaxis by Suppressing a Protein Kinase C- Raf/MEK/ERK Pathway*

  2009cited by this paper
• MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.

  2009cited by this paper
• Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7.

  2009cited by this paper
• Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.

  2009cited by this paper
• Going with the flow: JAK-STAT signaling in JMML.

  2008cited by this paper
• Gene silencing by DNA methylation in haematological malignancies

  2007cited by this paper
• An elaborate pathway required for Ras-mediated epigenetic silencing

  2007cited by this paper
• Targeting RAS signaling pathways in juvenile myelomonocytic leukemia.

  2007cited by this paper
• AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies

  2007cited by this paper
• Functional Analysis of Promoter CPG-Methylation using a CpG-Free Luciferase Reporter Vector

  2006cited by this paper
• Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.

  2005influential reference
• Aberrant methylation of the negative regulators RASSFIA, SHP‐1 and SOCS‐1 in myelodysplastic syndromes and acute myeloid leukaemia

  2005cited by this paper
• Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.

  2005influential reference
• Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia

  2005cited by this paper
• AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity

  2004influential reference
• Multiple Promoters Direct Expression of Three AKAP12 Isoforms with Distinct Subcellular and Tissue Distribution Profiles*

  2004cited by this paper
• Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1

  2004cited by this paper
• Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

  2003cited by this paper
• Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling.

  2001influential reference
• Gene trap insertion reveals two open reading frames in the mouse SSeCKS gene: the form predominantly detected in the nervous system is suppressed by the insertion while the other, specific of the testis, remains expressed.

  2001cited by this paper
• SSeCKS, a Major Protein Kinase C Substrate with Tumor Suppressor Activity, Regulates G1→S Progression by Controlling the Expression and Cellular Compartmentalization of Cyclin D

  2000cited by this paper
• SSeCKS gene expression in vascular smooth muscle cells: regulation by angiotensin II and a potential role in the regulation of PAI-1 gene expression.

  2000cited by this paper
• RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)

  1999cited by this paper
• Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: Correlation with culture confluency, cell cycle phase and serum response

  1997cited by this paper
• Chronic myelomonocytic leukemia in childhood. A retrospective analysis of 110 cases.

  1997cited by this paper
• Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

  1997cited by this paper
• Central role of tumour necrosis factor, GM‐CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia

  1992cited by this paper
• GASTROENTEROLOGY 2006;131:797–808 BASIC–ALIMENTARY TRACT A Genome-Wide Search Identifies Epigenetic Silencing of Somatostatin,

  year unknowninfluential reference

• Imaging Genomics Combined with Machine Learning to Explore the Impact of the Kinase Anchor Protein 12 Gene on Immunity and Survival in Gastric Cancer

  2024cites this paper
• Metastasis suppressor genes in clinical practice: are they druggable?

  2023cites this paper
• Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study

  2022cites this paper
• Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia

  2022cites this paper
• HDAC6-dependent deacetylation of AKAP12 dictates its ubiquitination and promotes colon cancer metastasis.

  2022cites this paper
• Identification of cystic fibrosis transmembrane conductance regulator as a prognostic marker for juvenile myelomonocytic leukemia via the whole-genome bisulfite sequencing of monozygotic twins and data mining

  2021cites this paper
• Development and Validation of a Prognostic Nomogram Based on DNA Methylation-Driven Genes for Patients With Ovarian Cancer

  2021cites this paper
• Current Treatment of Juvenile Myelomonocytic Leukemia

  2021cites this paper
• Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia

  2020cites this paper
• International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia

  2020cites this paper
• After 95 years, it's time to eRASe JMML.

  2020cites this paper
• Drugs that Regulate Local Cell Signaling: AKAP Targeting as a Therapeutic Option.

  2020cites this paper
• The diagnostic role of A-kinase anchoring protein 12, Bcl-2 and high mobility group box Protein-1 levels in breast cancer

  2019cites this paper
• Juvenile myelomonocytic leukemia: who's the driver at the wheel?

  2019cites this paper
• Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia

  2019cites this paper
• Diagnosis and treatment of juvenile myelomonocytic leukemia

  2019cites this paper
• Downregulation of microRNA-144 inhibits proliferation and promotes the apoptosis of myelodysplastic syndrome cells through the activation of the AKAP12-dependent ERK1/2 signaling pathway.

  2019cites this paper
• Aberrant DNA Methylation in Cutaneous Squamous Cell Carcinoma

  2019cites this paper
• The Mechanism and Influence of AKAP12 in Different Cancers.

  2018cites this paper
• Curcumol Controls Choriocarcinoma Stem-Like Cells Self-Renewal via Repression of DNA Methyltransferase (DNMT)- and Histone Deacetylase (HDAC)-Mediated Epigenetic Regulation

  2018cites this paper
• Panobinostat inhibits the proliferation of CD34+CD38−cells under stimulation of hematopoietic growth factors on AGM‐S3 cells in juvenile myelomonocytic leukemia

  2018cites this paper
• DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.

  2017cites this paper
• Turning the tide in myelodysplastic/myeloproliferative neoplasms

  2017cites this paper
• Epigenetic dysregulation of the erythropoietic transcription factor KLF1 and the β-like globin locus in juvenile myelomonocytic leukemia

  2017cites this paper
• ASB1 differential methylation in ischaemic cardiomyopathy: relationship with left ventricular performance in end‐stage heart failure patients

  2017cites this paper
• The role of A-kinase anchoring proteins in cancer development.

  2017cites this paper
• The origin of Juvenile Myelomonocytic Leukemia : Insights from developmental hematopoiesis

  2017cites this paper
• CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia

  2016cites this paper
• Prognostic Value of Gravin Versus Survivin Gene Expression in a Cohort of Egyptian Patients with Adult Acute Myeloid Leukemia

  2016cites this paper
• Short report Open Access

  2015cites this paper